Musculoskeletal system

Tao Ji, James Hayden, Bang H. Hoang

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Young sarcoma survivors not only have to deal with limb function-related problems, but they also have an increased mortality because of therapy-related late effects. This chapter presents late complications commonly observed after surgical treatment for pediatric patients with musculoskeletal malignancy. Due to the advancement of treatments, the survival and quality of life of pediatric patients with bone sarcomas has improved within the last few decades. Despite these important improvements, these patients are still subject to further health risks; therefore, it is imperative for them to be closely monitored as adults. Health problems can persist once treatment ends, along with comorbidities associated with previous cancer therapy. Adequate screening, surveillance and prevention are needed to minimize the impact of late effects of cancer treatment. Long-term follow-up for childhood sarcoma survivors typically begins when they are in remission and fully recovered from the immediate effects of treatment. It is important for all survivors to continue to have regular medical care for life. Most survivors need long-term follow-up visits once a year with their family doctor, pediatrician, oncologist and orthopedic surgeons, although the schedule may vary considerably depending on individual circumstances. The survivor or their parents should keep a treatment summary of their primary treatment, and give them to the healthcare providers for follow-up.

Original languageEnglish (US)
Title of host publicationHandbook of Long Term Care of The Childhood Cancer Survivor
PublisherSpringer US
Pages155-170
Number of pages16
ISBN (Print)9781489975843, 9781489975836
DOIs
StatePublished - Jan 1 2015

Fingerprint

Musculoskeletal System
Survivors
Sarcoma
Therapeutics
Pediatrics
Neoplasms
Health
Health Personnel
Comorbidity
Appointments and Schedules
Extremities
Parents
Quality of Life
Bone and Bones
Survival
Mortality

Keywords

  • Limb-length discrepancy
  • Limb-salvage
  • Osteonecrosis
  • Osteoporosis
  • Sarcoma

ASJC Scopus subject areas

  • Psychology(all)
  • Medicine(all)

Cite this

Ji, T., Hayden, J., & Hoang, B. H. (2015). Musculoskeletal system. In Handbook of Long Term Care of The Childhood Cancer Survivor (pp. 155-170). Springer US. https://doi.org/10.1007/978-1-4899-7584-3_11

Musculoskeletal system. / Ji, Tao; Hayden, James; Hoang, Bang H.

Handbook of Long Term Care of The Childhood Cancer Survivor. Springer US, 2015. p. 155-170.

Research output: Chapter in Book/Report/Conference proceedingChapter

Ji, T, Hayden, J & Hoang, BH 2015, Musculoskeletal system. in Handbook of Long Term Care of The Childhood Cancer Survivor. Springer US, pp. 155-170. https://doi.org/10.1007/978-1-4899-7584-3_11
Ji T, Hayden J, Hoang BH. Musculoskeletal system. In Handbook of Long Term Care of The Childhood Cancer Survivor. Springer US. 2015. p. 155-170 https://doi.org/10.1007/978-1-4899-7584-3_11
Ji, Tao ; Hayden, James ; Hoang, Bang H. / Musculoskeletal system. Handbook of Long Term Care of The Childhood Cancer Survivor. Springer US, 2015. pp. 155-170
@inbook{62a957defcdc481f9b2ac3556512247f,
title = "Musculoskeletal system",
abstract = "Young sarcoma survivors not only have to deal with limb function-related problems, but they also have an increased mortality because of therapy-related late effects. This chapter presents late complications commonly observed after surgical treatment for pediatric patients with musculoskeletal malignancy. Due to the advancement of treatments, the survival and quality of life of pediatric patients with bone sarcomas has improved within the last few decades. Despite these important improvements, these patients are still subject to further health risks; therefore, it is imperative for them to be closely monitored as adults. Health problems can persist once treatment ends, along with comorbidities associated with previous cancer therapy. Adequate screening, surveillance and prevention are needed to minimize the impact of late effects of cancer treatment. Long-term follow-up for childhood sarcoma survivors typically begins when they are in remission and fully recovered from the immediate effects of treatment. It is important for all survivors to continue to have regular medical care for life. Most survivors need long-term follow-up visits once a year with their family doctor, pediatrician, oncologist and orthopedic surgeons, although the schedule may vary considerably depending on individual circumstances. The survivor or their parents should keep a treatment summary of their primary treatment, and give them to the healthcare providers for follow-up.",
keywords = "Limb-length discrepancy, Limb-salvage, Osteonecrosis, Osteoporosis, Sarcoma",
author = "Tao Ji and James Hayden and Hoang, {Bang H.}",
year = "2015",
month = "1",
day = "1",
doi = "10.1007/978-1-4899-7584-3_11",
language = "English (US)",
isbn = "9781489975843",
pages = "155--170",
booktitle = "Handbook of Long Term Care of The Childhood Cancer Survivor",
publisher = "Springer US",

}

TY - CHAP

T1 - Musculoskeletal system

AU - Ji, Tao

AU - Hayden, James

AU - Hoang, Bang H.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Young sarcoma survivors not only have to deal with limb function-related problems, but they also have an increased mortality because of therapy-related late effects. This chapter presents late complications commonly observed after surgical treatment for pediatric patients with musculoskeletal malignancy. Due to the advancement of treatments, the survival and quality of life of pediatric patients with bone sarcomas has improved within the last few decades. Despite these important improvements, these patients are still subject to further health risks; therefore, it is imperative for them to be closely monitored as adults. Health problems can persist once treatment ends, along with comorbidities associated with previous cancer therapy. Adequate screening, surveillance and prevention are needed to minimize the impact of late effects of cancer treatment. Long-term follow-up for childhood sarcoma survivors typically begins when they are in remission and fully recovered from the immediate effects of treatment. It is important for all survivors to continue to have regular medical care for life. Most survivors need long-term follow-up visits once a year with their family doctor, pediatrician, oncologist and orthopedic surgeons, although the schedule may vary considerably depending on individual circumstances. The survivor or their parents should keep a treatment summary of their primary treatment, and give them to the healthcare providers for follow-up.

AB - Young sarcoma survivors not only have to deal with limb function-related problems, but they also have an increased mortality because of therapy-related late effects. This chapter presents late complications commonly observed after surgical treatment for pediatric patients with musculoskeletal malignancy. Due to the advancement of treatments, the survival and quality of life of pediatric patients with bone sarcomas has improved within the last few decades. Despite these important improvements, these patients are still subject to further health risks; therefore, it is imperative for them to be closely monitored as adults. Health problems can persist once treatment ends, along with comorbidities associated with previous cancer therapy. Adequate screening, surveillance and prevention are needed to minimize the impact of late effects of cancer treatment. Long-term follow-up for childhood sarcoma survivors typically begins when they are in remission and fully recovered from the immediate effects of treatment. It is important for all survivors to continue to have regular medical care for life. Most survivors need long-term follow-up visits once a year with their family doctor, pediatrician, oncologist and orthopedic surgeons, although the schedule may vary considerably depending on individual circumstances. The survivor or their parents should keep a treatment summary of their primary treatment, and give them to the healthcare providers for follow-up.

KW - Limb-length discrepancy

KW - Limb-salvage

KW - Osteonecrosis

KW - Osteoporosis

KW - Sarcoma

UR - http://www.scopus.com/inward/record.url?scp=84944613193&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84944613193&partnerID=8YFLogxK

U2 - 10.1007/978-1-4899-7584-3_11

DO - 10.1007/978-1-4899-7584-3_11

M3 - Chapter

AN - SCOPUS:84944613193

SN - 9781489975843

SN - 9781489975836

SP - 155

EP - 170

BT - Handbook of Long Term Care of The Childhood Cancer Survivor

PB - Springer US

ER -